STC:DBD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STC:DBD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD
Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD +2.90% 82 Days Payable is 77.96 as of Mar. 2026, which is 18% above its 10-year median of 66.11. GuruFocus rates STC:DBD with a GF Score™ of 82/100 and a GF Value™ of ₫52,212.47 (Fairly Valued). The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks worse than 72.05% on this metric.
Binh Dinh Pharmaceutical And Medical Equipment JSC's average Accounts Payable for the three months ended in Mar. 2026 was ₫208,575 Mil. Binh Dinh Pharmaceutical And Medical Equipment JSC's Cost of Goods Sold for the three months ended in Mar. 2026 was ₫244,138 Mil. Hence, Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable for the three months ended in Mar. 2026 was 77.96.
The historical rank and industry rank for Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable or its related term are showing as below:
During the past 8 years, Binh Dinh Pharmaceutical And Medical Equipment JSC's highest Days Payable was 89.62. The lowest was 38.89. And the median was 66.11.
Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable increased from Mar. 2025 (54.79) to Mar. 2026 (77.96). It may suggest that Binh Dinh Pharmaceutical And Medical Equipment JSC delayed paying its suppliers.
The historical data trend for Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data | |||||||||||||||||
| Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | Dec25 | |||||||||
| Days Payable | Get a 7-Day Free Trial | 38.89 | 60.34 | 61.78 | 58.36 | 70.44 | |||||||||||
| Binh Dinh Pharmaceutical And Medical Equipment JSC Quarterly Data | ||||||||||||||||||||
| Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Dec25 | Mar26 | |
| Days Payable | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
|
|
|
54.79 | 37.44 | 45.06 | 59.25 | 77.96 | ||
For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable distribution charts can be found below:
* The bar in red indicates where Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
| Days Payable (A: Dec. 2025 ) | |||||||||
| = | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
| = | ( (Accounts Payable (A: Dec. 2024 ) | + | Accounts Payable (A: Dec. 2025 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2025 ) | * | Days in Period |
| = | ( (160802.9 | + | 217824.029) | / | 2 ) | / | 981000.796 | * | 365 |
| = | 189313.4645 | / | 981000.796 | * | 365 | ||||
| = | 70.44 |
Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable for the quarter that ended in Mar. 2026 is calculated as:
| Days Payable (Q: Mar. 2026 ) | |||||||||
| = | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
| = | ( (Accounts Payable (Q: Dec. 2025 ) | + | Accounts Payable (Q: Mar. 2026 )) | / | count ) | / | Cost of Goods Sold (Q: Mar. 2026 ) | * | Days in Period |
| = | ( (217824.029 | + | 199326.1) | / | 2 ) | / | 244137.841 | * | 365 / 4 |
| = | 208575.0645 | / | 244137.841 | * | 365 / 4 | ||||
| = | 77.96 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be overvalued. The current stock price of ₫53,200.00 is trading 1.9% above its estimated GF Value™ of ₫52,212.47. GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.